Sacituzumab Tirumotecan

OncoDaily

News Feed Opinion Blog Career Insight Dialogues Celebrities Oncolibrary

Positive Societies Drugs Stories History Cancer Center Near Me Cancer Types Immune Oncology Oncologist Near Me

May, 2025

Sacituzumab Tirumotecan

Apr 12, 2025, 02:19 | Blog

Raffaele Colombo: Sacituzumab Govitecan (SG) vs Sacituzumab Tirumotecan (Sac-TMT)

Raffaele Colombo, Associate Director of Medicinal Chemistry at Zymeworks, shared a post on X: "Sacituzumab…

Mar 11, 2025, 09:56 | Drugs

Raffaele Colombo: Sacituzumab tirumotecan was approved for a second indication by NMPA in China

Raffaele Colombo, Associate Director of Medicinal Chemistry at Zymeworks, shared a post on X: "Sacituzumab tirumotecan approved…

Dec 29, 2024, 10:16 | Insight

Paolo Tarantino: Top 10 ADC Milestones of 2024

Paolo Tarantino, Clinical Research Fellow at the Dana-Farber Cancer Institute, shared on X: “2024 has…

Nov 30, 2024, 16:22 | Drugs

Sacituzumab Tirumotecan Earns Approval in China in Pretreated Advanced TNBC

Sacituzumab govitecan is the first TROP2-targeted antibody-drug conjugate (ADC) and the first ADC developed in…

Apr 30, 2024, 07:31 | Insight

Top 5 posts of the week by Cancer Network

Cancer Network shared on their X/Twitter page: "View our top 5 posts of the week:…

All: 5 Posts: 1 - 100

'

Oncologist Near Me – Yan Leyfman: A Voice for Innovation, Mentorship, and Impact in Oncology

'

Richard Goldberg: Agenus Anticipates Interacting with FDA with New Data Coming at ESMO-GI 2025

'

USA vs Europe: Who Does Cancer Screening Better?

'

A Call for Peace from the Frontlines of Pediatric Oncology by the POEM Group

'

Servier Acquires Precision Therapy for Acute Leukemias from BioNova Pharmaceuticals

Special Coverage

Challenging the Status Quo in Colorectal Cancer 2024
December 6-8, 2024
ESMO 2024 Congress
September 13-17, 2024
ASCO Annual Meeting
May 30 - June 4, 2024
Yvonne Award 2024
May 31, 2024
OncoThon 2024, Online
Feb. 15, 2024
Global Summit on War & Cancer 2023, Online
Dec. 14-16, 2023